Evidence map›Paper›PMID 19996106›Full record

ArticleThe Journal of biological chemistry2010

Huntingtin-associated protein-1 interacts with pro-brain-derived neurotrophic factor and mediates its transport and release.

Linda Lin-yan Wu, Yongjun Fan, Shihua Li, Xiao-Jiang Li, Xin-Fu Zhou

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 77 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Biological functions and potential therapeutic applications of huntingtin-associated protein 1: progress and prospects.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2022
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Proteotoxicity and Neurodegenerative Diseases.International journal of molecular sciences · 2020
    Review
  16. Article
  17. Article
  18. The Role of Adenosine Tone and Adenosine Receptors in Huntington's Disease.Journal of caffeine and adenosine research · 2018
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Linda Lin-yan WuDepartment of Human Physiology and Centre for Neuroscience, Flinders University, GPO Box 2100, Adelaide, South Australia 5001, Australia.
Yongjun Fan
Shihua Li
Xiao-Jiang Li
Xin-Fu Zhou
Emory University · USFlinders University · AU

Funding

Neuronal function of huntingtin-associated proteinR01NS036232 · NINDS · EMORY UNIVERSITY · PI ESCAYG, ANDREW P · 1998 to 2021
$6.7M
Polyglutamine expansion and neuropathologyR01NS045016 · NINDS · EMORY UNIVERSITY · PI LI, SHI-HUA · 2004 to 2013
$2.9M
Glial huntingtin and neuronal excitotoxicityR01AG031153 · NIA · EMORY UNIVERSITY · PI LI, SHI-HUA · 2009 to 2013
$1.5M
NIA NIH HHS R01 AG031153NINDS NIH HHS R01 NS036232NINDS NIH HHS R01 NS045016
6 · The paper itself

Abstract

Brain-derived neurotrophic factor (BDNF) plays a pivotal role in brain development and synaptic plasticity. It is synthesized as a precursor (pro-BDNF), sorted into the secretory pathway, transported along dendrites and axons, and released in an activity-dependent manner. Mutant Huntingtin with expanded polyglutamine (polyQ) and the V66M polymorphism of BDNF reduce the dendritic distribution and axonal transport of BDNF. However, the mechanism underlying this defective transport remains unclear. Here, we report that Huntingtin-associated protein-1 (HAP1) interacts with the prodomain of BDNF and that the interaction was reduced in the presence of polyQ-expanded Huntingtin and BDNF V66M. Consistently, there was reduced coimmunoprecipitation of pro-BDNF with HAP1 in the brain homogenate of Huntington disease. Pro-BDNF distribution in the neuronal processes and its accumulation in the proximal and distal segments of crushed sciatic nerve and the activity-dependent release of pro-BDNF were abolished in HAP1(-/-) mice. These results suggest that HAP1 may participate in axonal transport and activity-dependent release of pro-BDNF by interacting with the BDNF prodomain. Accordingly, the decreased interaction between HAP1 and pro-BDNF in Huntington disease may reduce the release and transport of BDNF.

Indexed as

AnimalsAxonsBrain-Derived Neurotrophic FactorHumansHuntingtin ProteinHuntington DiseaseMiceMice, KnockoutMutation, MissenseNerve Tissue ProteinsNuclear ProteinsPeptidesPolymorphism, GeneticProtein PrecursorsProtein Structure, TertiaryProtein TransportBrain-Derived Neurotrophic Factorbrain-derived neurotrophic factor precursorHAP1 protein, humanHap1 protein, mouseHTT protein, humanHtt protein, mouseHuntingtin ProteinNerve Tissue ProteinsNuclear ProteinsPeptidespolyglutamineProtein Precursors

Identifiers

PMID19996106
PMCPMC2820788
OpenAlexW2118520852

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.